News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
308,536 Results
Type
Article (14203)
Company Profile (108)
Press Release (294225)
Section
Business (99304)
Career Advice (569)
Deals (20502)
Drug Delivery (66)
Drug Development (39941)
Employer Resources (49)
FDA (6983)
Job Trends (7167)
News (171050)
Policy (15522)
Tag
Academia (502)
Alliances (26426)
Alzheimer's disease (463)
Approvals (7010)
Artificial intelligence (89)
Bankruptcy (185)
Best Places to Work (5269)
Breast cancer (83)
Cancer (613)
Cardiovascular disease (55)
Career advice (498)
Cell therapy (85)
Clinical research (33470)
Collaboration (294)
Compensation (128)
COVID-19 (804)
C-suite (91)
Data (613)
Diabetes (77)
Diagnostics (1884)
Drug pricing (62)
Earnings (35952)
Events (43795)
Executive appointments (340)
FDA (7353)
Funding (218)
Gene therapy (88)
GLP-1 (332)
Government (1398)
Healthcare (5061)
Infectious disease (836)
Inflammatory bowel disease (59)
Interviews (76)
IPO (9176)
Job creations (2149)
Job search strategy (447)
Layoffs (176)
Legal (3945)
Lung cancer (90)
Manufacturing (130)
Medical device (2921)
Medtech (2923)
Mergers & acquisitions (11615)
Metabolic disorders (225)
Neuroscience (625)
NextGen: Class of 2025 (2219)
Non-profit (722)
Northern California (732)
Obesity (126)
Opinion (118)
Patents (100)
People (31646)
Pharmaceutical (64)
Phase I (9008)
Phase II (14387)
Phase III (12355)
Pipeline (314)
Postmarket research (1427)
Preclinical (3602)
Radiopharmaceuticals (135)
Rare diseases (152)
Real estate (2941)
Regulatory (10933)
Research institute (650)
Resumes & cover letters (67)
Southern California (766)
Startups (1883)
United States (7619)
Vaccines (147)
Weight loss (88)
Date
Today (3)
Last 7 days (276)
Last 30 days (1173)
Last 365 days (15042)
2025 (2030)
2024 (15347)
2023 (17676)
2022 (23558)
2021 (24856)
2020 (23766)
2019 (18185)
2018 (14264)
2017 (16086)
2016 (14953)
2015 (18006)
2014 (14142)
2013 (11993)
2012 (12940)
2011 (13195)
2010 (12114)
Location
Africa (316)
Arizona (66)
Asia (21970)
Australia (2861)
California (1826)
Canada (867)
China (205)
Colorado (70)
Connecticut (88)
Europe (41735)
Florida (331)
Illinois (190)
Indiana (130)
Japan (77)
Kansas (58)
Maryland (262)
Massachusetts (1460)
Michigan (80)
Minnesota (98)
New Jersey (721)
New York (584)
North Carolina (462)
Northern California (732)
Ohio (56)
Pennsylvania (454)
South America (532)
Southern California (766)
Texas (264)
Virginia (60)
Washington State (133)
308,536 Results for "ascendia pharmaceuticals llc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Ascendia Pharmaceutical Solutions Launched to Meet Drug Development and Manufacturing Needs
December 10, 2024
·
2 min read
Ampio Selects Ascendia Pharmaceuticals, Inc. to Provide CDMO Services to Support Clinical Development of OA-201
Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) (the “Company) today announced that it has selected Ascendia Pharmaceuticals, Inc. (“Ascendia”) to provide services to support the clinical development of OA-201, a novel therapeutic for the treatment of symptomatic osteoarthritis pain.
October 5, 2023
·
5 min read
Pharm Country
Ascendia Pharmaceuticals Develops Novel Nanoemulsion IV Formulation for Clopidogrel that Received IND Approval
Ascendia Pharmaceuticals CEO Jim Huang, Ph.D. announces Ascendia’s patented EmulSol® nanotechnology has been used to develop a novel nanoemulsion IV formulation for clopidogrel that has received Investigational New Drug (IND) approval from the Food & Drug Administration (FDA).
June 27, 2023
·
2 min read
Pharm Country
Ascendia® Named to 2023 Inc. 5000 List of America’s Fastest-Growing Private Companies for the Fourth Consecutive Year
Ascendia Pharmaceuticals® proudly announces it has been named to the prestigious 2023 Inc. 5000 list for the fourth consecutive year.
August 24, 2023
·
3 min read
Press Releases
Acella Pharmaceuticals, LLC, an Alora Pharmaceuticals, LLC Subsidiary, Partners with Paloma Health for Hypothyroidism Patients
October 23, 2024
·
2 min read
Press Releases
Marius Pharmaceuticals Partners with US Specialists Management, LLC (“USSM”) Through Affiliated Urologic In-office Dispensaries
January 14, 2025
·
7 min read
Press Releases
Pharma Logistics, LLC and Rx Reverse Distributors, Inc. Unite, Setting a New Standard in Pharmaceutical Reverse Distribution
January 6, 2025
·
3 min read
Press Releases
Innovative Lab Services LLC Acquires PL Consultants, LLC to Expand Scientific Capabilities and Service Offerings
January 15, 2025
·
2 min read
Press Releases
ITF Therapeutics LLC Announces Multiple Data Presentations at 2025 MDA Clinical and Scientific Conference
February 21, 2025
·
7 min read
Press Releases
Cycle Pharma Acquires Banner Life Sciences, LLC
January 13, 2025
·
17 min read
1 of 30,854
Next
